Methods of treating skin cancer by administering PD-1 inhibitor
The present disclosure provides methods of treating, reducing the severity of, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present disclosure comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonis...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Chinese English |
| Published |
11.07.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
| Summary: | The present disclosure provides methods of treating, reducing the severity of, or inhibiting the growth of cancer (e.g., skin cancer). The methods of the present disclosure comprise administering to a subject in need thereof a therapeutically effective amount of a programmed death 1 (PD-1) antagonist (e.g., an anti-PD-1 antibody). In certain embodiments, the skin cancer is skin squamous cell carcinoma or basal cell carcinoma.
本公开提供了治疗癌症(例如,皮肤癌),降低其严重性或抑制癌症生长的方法。本公开的方法包括向需要其的受试者施用治疗有效量的程序性死亡1(PD-1)拮抗剂(例如,抗PD-1抗体)。在某些实施方案中,皮肤癌是皮肤鳞状细胞癌或基底细胞癌。 |
|---|---|
| Bibliography: | Application Number: CN202310111383 |